Home -> Law Blog Directory -> Personal Injury Law Blogs -> Bodily Injury Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Bodily Injury BlogDOJ Joins Suit Over Pfizer Illegal Drug Marketing
By Edward Bills
The U.S. Department of Justice has joined a lawsuit against Pfizer and its subsidiary Wyeth Pharmaceuticals over the alleged illegal marketing of the drug Rapamune. The suit claimed the company tried to market Rapamune, which is taken by kidney transplant patients, as beneficial to “heart, lung, liver and pancreas transplants” without FDA approval. The suit stemmed from a whistle-blower complaint filed in 2005. Pfizer has recently been the target of similar cases, settling for $2.3 billion in a suit last year.
Full post as published by Bodily Injury Blog on September 22, 2010 (boomark / email).
Illegal Immigrant Responsibility and Reform Act of 1996
Explanation of the controversial illegal immigration law
Mesothelioma Law Suit
Asbestos Exposure
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Bextra Product Recall
Find a Bextra Lawyer
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Wyeth Sued Over Rapamune Transplant Drug
Illegal Marketing of Rapamune Sparks Lawsuit
Forest Laboratories Potentially Illegal Marketing
Forest Laboratories Potentially Illegal Marketing
Vytorin Marketing
alleged false claims in marketing campaign.
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Pfizer, Pharmacia
Found Guilty of Medicaid Fraud
Coke
Sued Over Marketing of "VitaminWater"

Blue Cross Blue Shield Sues Pfizer Over Drug Marketing and Illegal Kickbacks
Unsealed Lipitor lawsuit alleges defective marketing
Pfizer Will Pay Record $2.3-Billion Settlement For Fraudulent Marketing
Whistleblower suit charges Pfizer with off-label marketing of Lipitor
U.S. joins FCA suit against drug company accused of off-label marketing
Pfizer, Inc. faces lawsuit after alleged deceptive marketing








